BeiGene Selects TrialScope for Clinical Trial Disclosure and Transparency

newseditor

May 27, 2020

Jersey City, NJ, May 27, 2020 — TrialScope, the global leader in clinical trial transparency technology, adds BeiGene to its growing list of global partners.

BeiGene has selected the TrialScope Disclose™ platform to manage disclosure of its clinical trials, aiding in compliance with evolving Federal Drug Administration and EudraCT software regulations for clinical trial registration and reporting. BeiGene sought a centralized, validated disclosure management platform, one that would modernize and automate the full range of clinical trial disclosure activities globally, from protocol to registration to results. TrialScope Disclose™ delivers an intelligent workflow engine that will help the BeiGene disclosure team streamline data entry, manage approval cycles, and submit trial information quicker and more accurately than ever before.

BeiGene conducts its clinical research in keeping with Good Clinical Practice (GCP), the universal ethical and scientific quality standard for conducting clinical trials, and applies it to all aspects of its clinical trial processes. Under these guidelines, BeiGene views quality as a continuum, from trial design through recording, reporting and dissemination of trial results.

“We are thrilled to have BeiGene as a new partner,” said TrialScope CEO Jeff Kozloff. “BeiGene’s mission – courage, persistent innovation and challenging the status quo – dovetails with our own mission at TrialScope. Ultimately, we seek better outcomes for patients and better health for all, and it all starts with data transparency.”

For more information on TrialScope or its TrialScope Disclose™ technology, visit TrialScope.com.

About TrialScope 

TrialScope technology powers the authoritative clinical trial data hub that enables sponsors to streamline trial disclosure, expand access to data, and connect the dots between patients and clinical trials. Seventeen of the top 20 industry clinical trial sponsors rely on TrialScope’s suite of data transparency, disclosure, patient engagement and recruiting solutions to build public trust and accelerate clinical development timelines. To learn more about TrialScope, visit TrialScope.com

About BeiGene

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Its 3,500-plus employees in China, the United States, Australia and Europe are committed to expediting the development of a diverse pipeline of novel therapeutics for cancer.